The billionaire founder of Robinhood shared his grueling journey to build the financial app with Gunjan Banerji in the latest episode of The WSJ Money Interview.
OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE
FORM 8.1(a) & (b)
(Opening Position Disclosure)
ACGME Announces Recipients of Back to Bedside Funding for 2026-2028 Cycle
Chicago, IL, June 24, 2026 (GLOBE NEWSWIRE) — The Accreditation Council for Graduate Medical Education (ACGME) has selected 23 resident- and fellow-led teams to receive funding as part of the fifth cycle of Back to Bedside, an initiative developed by residents and fellows to support innovative projects that enhance the physician-patient connection and improve the clinical learning environment in graduate medical education.
Continuation of the implementation of Atos Group’s refinancing strategy
Continuation of the implementation of Atos Group’s refinancing strategy
Poursuite de la mise en œuvre de la stratégie de refinancement d’Atos Group
Poursuite de la mise en œuvre de la stratégie de refinancement d’Atos Group
You Didn’t Choose to Bet Your Retirement on AI. Your 401(k) Did It Without Asking.
Most Americans have no idea their retirement account is heavily concentrated in a handful of AI stocks. A former Pentagon advisor explains what that means if the trade goes wrong.
Most Americans have no idea their retirement account is heavily concentrated in a handful of AI stocks. A former Pentagon advisor explains what that means if the trade goes wrong.
Radiopharmaceutical CDMO Market Size to Reach USD 8.14 Billion by 2035 | SNS Insider
The U.S. Radiopharmaceutical CDMO Market is projected to grow from USD 1.29 Billion in 2025 to USD 3.00 Billion by 2035, while Europe is expected to expand from USD 1.09 Billion to USD 3.24 Billion, supported by increasing radioligand therapy commercialization and expanding precision oncology manufacturing capacity.
The U.S. Radiopharmaceutical CDMO Market is projected to grow from USD 1.29 Billion in 2025 to USD 3.00 Billion by 2035, while Europe is expected to expand from USD 1.09 Billion to USD 3.24 Billion, supported by increasing radioligand therapy commercialization and expanding precision oncology manufacturing capacity.
Canon Digital Press Designs Win Red Dot Awards
Melville, NY, June 24, 2026 (GLOBE NEWSWIRE) — Canon Inc., the parent company of Canon U.S.A., Inc., a leader in digital imaging solutions, announced that two Canon commercial printers–the varioPRINT iX1700 sheetfed inkjet digital press and Colorado XL-series large-format hybrid printers–received a prestigious Red Dot Design Award: Product Design 2026, building on their iF Design Award wins in Germany.
Matic Secures Minority Investment From Primus Capital and Acquires Policygenius’ Property and Casualty Insurance Book
Portfolio acquisition and new capital investment fuel Matic’s next phase of growth
Portfolio acquisition and new capital investment fuel Matic’s next phase of growth
The Key to Healthy Aging: NMN Supplements Shown to Boost NAD+ Levels
Life Extension launches NMN supplements
Life Extension launches NMN supplements
New York City Regional Center-Managed Entity Provides Funding for 12th Public Charter School in New York City
Closed transaction provided $15 million in New Markets Tax Credit financing for the construction of a new K-12 public charter school in the Bronx.
Closed transaction provided $15 million in New Markets Tax Credit financing for the construction of a new K-12 public charter school in the Bronx.
BBG Advanced Therapies to Collaborate with VERIGRAFT to Support U.S. Development Readiness for New Vein Therapy
The collaboration is an important milestone in the Swedish company’s preparations for clinical development activities in the United States. BBG AT will provide support for key U.S. development and manufacturing readiness activities, including donor vein sourcing, manufacturing and testing-related operations, as well as operational preparation for U.S. clinical trials.
The collaboration is an important milestone in the Swedish company’s preparations for clinical development activities in the United States. BBG AT will provide support for key U.S. development and manufacturing readiness activities, including donor vein sourcing, manufacturing and testing-related operations, as well as operational preparation for U.S. clinical trials.
Lucas Oil helps ensure boat and marine owners have a safe summer season
Additives and lubricants leader shares tips and tricks for time spent on the water
Additives and lubricants leader shares tips and tricks for time spent on the water
“Dermatologic Surgery” Journal Releases Special Issue on GLP-1 and the Future of Aesthetic Outcomes
Guest Editors Drs. Kavita Mariwalla, Ardalan Minokadeh and Andreas Nikolis curated a collection of peer-reviewed articles on glucagon-like peptide-1 (GLP-1) receptor agonists to publish early insights, raise questions for consideration and start building a more cohesive understanding of what comes next.
Guest Editors Drs. Kavita Mariwalla, Ardalan Minokadeh and Andreas Nikolis curated a collection of peer-reviewed articles on glucagon-like peptide-1 (GLP-1) receptor agonists to publish early insights, raise questions for consideration and start building a more cohesive understanding of what comes next.
Equalis Group Awards Gordian’s Job Order Contracts to Newly Selected Contractors Across Illinois
Illinois agencies now have streamlined access to Gordian’s Job Order Contracting (JOC) solutions through newly awarded Equalis contract #COG-2176A.
Illinois agencies now have streamlined access to Gordian’s Job Order Contracting (JOC) solutions through newly awarded Equalis contract #COG-2176A.
Sentient Foundation Commits $42 Million to Advance Open Source AGI
San Francisco, CA, June 24th, 2026, FinanceWire, June 24, 2026 (GLOBE NEWSWIRE) — One of the largest commitments dedicated exclusively to open-source AGI, supporting the developers, researchers, and startups building AI in the open.